Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
10/28/2020
CStone and LegoChem Biosciences Enter Global Licensing Agreement for N...
10/28/2020
NMPA Approves Label Update for AstraZeneca's Forxiga (dapagliflozin)...
10/27/2020
CStone and EQRx Enter Global Strategic Partnership for Two Immune Chec...
10/27/2020
EdiGene Files IND for Its CRISPR/Cas 9 Gene-editing Hematopoietic Stem...
10/27/2020
Live Podcast - VC & Impact Investing in China: Investing in a Time of ...
10/27/2020
Simcere Pharma Gets New Shot in the Arm with $438M Hong Kong IPO
10/27/2020
CDE Seeks Comments on the Draft Measures on Transparency of Drug Evalu...
10/27/2020
NMPA Announces Designation of 100 National Drug Abuse Surveillance Pos...
10/27/2020
BioPlan - Biologics Manufacturing In China: Competition Heats Up Among...
10/27/2020
Promoting Innovation With Enhanced Protection And Enforcement Measurem...
10/27/2020
China Publishes Anti-Monopoly Guidelines on Intellectual Property
10/23/2020
Amgen's China Strategy Forward: Collaborating with Local Partners on W...
10/23/2020
China Signs Off on PRC Biosecurity Law: What This Means for Industry P...
10/23/2020
Follow WiCON|Pharma China on Twitter and Facebook for Latest Chinese P...
10/23/2020
CDE Issues the General Requirements for Oral Tablet Scoring Design and...
10/23/2020
Recent Executive Moves
10/22/2020
BioNTech to Make in Germany the Covid-19 Vaccine for China Market
10/22/2020
AstraZeneca and Realcan Pharma Enter Distribution Deal in China
10/22/2020
Fosun-owned Gland Pharma Granted Approval for Indian IPO
10/22/2020
Priority Review Granted to Ascentage Pharma's NDA for Olverembatinib (...
10/22/2020
CDE Issues the Guidance for Acceptance and Evaluation of TCMs
10/22/2020
CDE Issues the Two Generic Drug Research Guidelines for Doxorubicin an...
10/22/2020
COHGRM Issues Notice on Further Optimizing the Administrative Approval...
10/22/2020
China's Newly Approved Amendment to Patent Law Changes the Landscape o...
10/22/2020
Nation's Healthcare Expands to Cover All Urban and Rural areas
10/22/2020
Gowling WLG: Ten Highlights of China's New Patent Law
10/21/2020
China Forges Ahead with Draft Measures for New Patent Linkage System
10/21/2020
China's Draft Measures on Patent Linkage: Implications for the Future ...
10/21/2020
Chinese Online Pharmacy Dingdang Kuaiyao Raises CNY 1B
10/21/2020
Hogan Lovells: China Adopts Revised Patent Law with Hatch-Waxman-Like ...
Page:
215
/
775
Total number of articles:
23222
:
[First]
[<<]
[213]
[214]
[215]
[216]
[217]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit